Literature DB >> 22391253

Age as a risk factor.

Ravi Dhingra1, Ramachandran S Vasan.   

Abstract

The risk of developing cardiovascular disease (CVD) is generally dependent on the presence or absence of traditional risk factors. Age is a well-known traditional risk factor, generally considered nonmodifiable. This review discusses the common use of individual age in prediction of CVD incidence using different risk scores, whether or not age as a risk factor can be modified, the methods used to evaluate long-term and short-term CVD risk, appropriate communication of individual risk based on age group and CVD risk, and the influence of age on cardiac and vascular risk factors. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22391253      PMCID: PMC3297980          DOI: 10.1016/j.mcna.2011.11.003

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  25 in total

1.  Updated New Zealand cardiovascular disease risk-benefit prediction guide.

Authors:  R Jackson
Journal:  BMJ       Date:  2000-03-11

2.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

3.  Lifetime risk for developing congestive heart failure: the Framingham Heart Study.

Authors:  Donald M Lloyd-Jones; Martin G Larson; Eric P Leip; Alexa Beiser; Ralph B D'Agostino; William B Kannel; Joanne M Murabito; Ramachandran S Vasan; Emelia J Benjamin; Daniel Levy
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

4.  Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.

Authors:  Ramachandran S Vasan; Alexa Beiser; Sudha Seshadri; Martin G Larson; William B Kannel; Ralph B D'Agostino; Daniel Levy
Journal:  JAMA       Date:  2002-02-27       Impact factor: 56.272

5.  Lifetime risk of developing coronary heart disease.

Authors:  D M Lloyd-Jones; M G Larson; A Beiser; D Levy
Journal:  Lancet       Date:  1999-01-09       Impact factor: 79.321

Review 6.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Authors:  Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal:  Circulation       Date:  2004-07-13       Impact factor: 29.690

7.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Authors:  R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

Review 8.  Communicating evidence for participatory decision making.

Authors:  Ronald M Epstein; Brian S Alper; Timothy E Quill
Journal:  JAMA       Date:  2004-05-19       Impact factor: 56.272

9.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

10.  Factors associated with survival to 75 years of age in middle-aged men and women. The Framingham Study.

Authors:  R J Goldberg; M Larson; D Levy
Journal:  Arch Intern Med       Date:  1996-03-11
View more
  75 in total

1.  New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects.

Authors:  Ana Paula Davel; Iris Z Jaffe; Rita C Tostes; Frederic Jaisser; Eric J Belin de Chantemèle
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-29       Impact factor: 4.733

2.  Cardiovascular phenotype of mice lacking 3-mercaptopyruvate sulfurtransferase.

Authors:  Maria Peleli; Sofia-Iris Bibli; Zhen Li; Athanasia Chatzianastasiou; Aimilia Varela; Antonia Katsouda; Sven Zukunft; Mariarosaria Bucci; Valentina Vellecco; Constantinos H Davos; Noriyuki Nagahara; Giuseppe Cirino; Ingrid Fleming; David J Lefer; Andreas Papapetropoulos
Journal:  Biochem Pharmacol       Date:  2020-02-04       Impact factor: 5.858

Review 3.  Reversing age-associated arterial dysfunction: insight from preclinical models.

Authors:  Venkateswara R Gogulamudi; Jinjin Cai; Lisa A Lesniewski
Journal:  J Appl Physiol (1985)       Date:  2018-05-10

4.  Smooth Muscle Cell-Mineralocorticoid Receptor as a Mediator of Cardiovascular Stiffness With Aging.

Authors:  Seung Kyum Kim; Amy T McCurley; Jennifer J DuPont; Mark Aronovitz; M Elizabeth Moss; Isaac E Stillman; S Ananth Karumanchi; Demetra D Christou; Iris Z Jaffe
Journal:  Hypertension       Date:  2018-02-20       Impact factor: 10.190

5.  DNA Methylation and Age-Independent Cardiovascular Risk, an Epigenome-Wide Approach: The REGICOR Study (REgistre GIroní del COR).

Authors:  Alba Fernández-Sanlés; Sergi Sayols-Baixeras; Santiago Curcio; Isaac Subirana; Jaume Marrugat; Roberto Elosua
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-11       Impact factor: 8.311

Review 6.  T-cell recruitment to the heart: friendly guests or unwelcome visitors?

Authors:  Robert M Blanton; Francisco J Carrillo-Salinas; Pilar Alcaide
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-10       Impact factor: 4.733

Review 7.  Significance of psychosocial factors in cardiology: update 2018 : Position paper of the German Cardiac Society.

Authors:  Christian Albus; Christiane Waller; Kurt Fritzsche; Hilka Gunold; Markus Haass; Bettina Hamann; Ingrid Kindermann; Volker Köllner; Boris Leithäuser; Nikolaus Marx; Malte Meesmann; Matthias Michal; Joram Ronel; Martin Scherer; Volker Schrader; Bernhard Schwaab; Cora Stefanie Weber; Christoph Herrmann-Lingen
Journal:  Clin Res Cardiol       Date:  2019-05-10       Impact factor: 5.460

Review 8.  Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.

Authors:  Nienke Z Borren; Ashwin N Ananthakrishnan
Journal:  Clin Gastroenterol Hepatol       Date:  2019-01-04       Impact factor: 11.382

9.  Trait anxiety mimics age-related cardiovascular autonomic modulation in young adults.

Authors:  M A Sanchez-Gonzalez; P Guzik; R W May; A P Koutnik; R Hughes; S Muniz; M Kabbaj; F D Fincham
Journal:  J Hum Hypertens       Date:  2014-08-28       Impact factor: 3.012

10.  TP53 single nucleotide polymorphism (rs1042522) in Iranian patients with coronary artery disease.

Authors:  Versa Omrani-Nava; Akbar Hedayatizadeh-Omran; Reza Alizadeh-Navaei; Vahid Mokhberi; Rozita Jalalian; Ghasem Janbabaei; Omolbanin Amjadi; Ghasem Rahmatpour; Amir Mozaffari
Journal:  Biomed Rep       Date:  2018-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.